Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.

Kimura T, Koya RC, Anselmi L, Sternini C, Wang HJ, Comin-Anduix B, Prins RM, Faure-Kumar E, Rozengurt N, Cui Y, Kasahara N, Stripecke R.

Mol Ther. 2007 Jul;15(7):1390-9. Epub 2007 May 1.

2.

Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.

Ciré S, Da Rocha S, Yao R, Fisson S, Buchholz CJ, Collins MK, Galy A.

PLoS One. 2014 Jul 24;9(7):e101644. doi: 10.1371/journal.pone.0101644. eCollection 2014.

3.

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.

Pincha M, Salguero G, Wedekind D, Sundarasetty BS, Lin A, Kasahara N, Brugman MH, Jirmo AC, Modlich U, Gutzmer R, Büsche G, Ganser A, Stripecke R.

Gene Ther. 2011 Aug;18(8):750-64. doi: 10.1038/gt.2011.15. Epub 2011 Mar 17.

4.

In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.

Joyeux L, Danzer E, Limberis MP, Zoltick PW, Radu A, Flake AW, Davey MG.

Hum Gene Ther Methods. 2014 Jun;25(3):197-205. doi: 10.1089/hgtb.2013.143. Epub 2014 Apr 21.

5.

Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression.

Ngai SC, Rosli R, Nordin N, Veerakumarasivam A, Abdullah S.

Gene. 2012 May 1;498(2):231-6. doi: 10.1016/j.gene.2012.01.071. Epub 2012 Feb 16.

PMID:
22366305
6.

Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.

Mao Y, Yan R, Li A, Zhang Y, Li J, Du H, Chen B, Wei W, Zhang Y, Sumners C, Zheng H, Li H.

Int J Med Sci. 2015 May 15;12(5):407-15. doi: 10.7150/ijms.11270. eCollection 2015.

7.

The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen-presenting cells but not by CD4+CD25+ regulatory T cells.

Annoni A, Battaglia M, Follenzi A, Lombardo A, Sergi-Sergi L, Naldini L, Roncarolo MG.

Blood. 2007 Sep 15;110(6):1788-96. Epub 2007 May 10.

8.

Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors.

Gruh I, Wunderlich S, Winkler M, Schwanke K, Heinke J, Blömer U, Ruhparwar A, Rohde B, Li RK, Haverich A, Martin U.

J Gene Med. 2008 Jan;10(1):21-32.

PMID:
18022932
9.

Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.

Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.

Eur J Immunol. 2009 Oct;39(10):2725-36. doi: 10.1002/eji.200939543.

10.

Intravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis.

van den Brand BT, Vermeij EA, Waterborg CE, Arntz OJ, Kracht M, Bennink MB, van den Berg WB, van de Loo FA.

PLoS One. 2013;8(2):e55356. doi: 10.1371/journal.pone.0055356. Epub 2013 Feb 4.

12.

Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Uhlig KM, Schülke S, Scheuplein VA, Malczyk AH, Reusch J, Kugelmann S, Muth A, Koch V, Hutzler S, Bodmer BS, Schambach A, Buchholz CJ, Waibler Z, Scheurer S, Mühlebach MD.

J Virol. 2015 Sep;89(17):9044-60. doi: 10.1128/JVI.00844-15. Epub 2015 Jun 17.

13.

Characterization of the properties of seven promoters in the motor cortex of rats and monkeys after lentiviral vector-mediated gene transfer.

Yaguchi M, Ohashi Y, Tsubota T, Sato A, Koyano KW, Wang N, Miyashita Y.

Hum Gene Ther Methods. 2013 Dec;24(6):333-44. doi: 10.1089/hgtb.2012.238. Epub 2013 Oct 22.

14.

The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome.

Goyvaerts C, Broos K, Escors D, Heirman C, Raes G, De Baetselier P, Thielemans K, Breckpot K.

Eur J Immunol. 2015 Dec;45(12):3351-61. doi: 10.1002/eji.201545559. Epub 2015 Oct 27.

15.

Targeted transgene expression in rat brain using lentiviral vectors.

Jakobsson J, Ericson C, Jansson M, Björk E, Lundberg C.

J Neurosci Res. 2003 Sep 15;73(6):876-85.

PMID:
12949915
16.

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

Daenthanasanmak A, Salguero G, Borchers S, Figueiredo C, Jacobs R, Sundarasetty BS, Schneider A, Schambach A, Eiz-Vesper B, Blasczyk R, Weissinger EM, Ganser A, Stripecke R.

Vaccine. 2012 Jul 20;30(34):5118-31. doi: 10.1016/j.vaccine.2012.05.063. Epub 2012 Jun 9.

17.

Targeting transgene to the heart and liver with AAV9 by different promoters.

Chen BD, He CH, Chen XC, Pan S, Liu F, Ma X, Li XM, Gai MT, Tao J, Ma YT, Yang YN, Gao XM.

Clin Exp Pharmacol Physiol. 2015 Oct;42(10):1108-17. doi: 10.1111/1440-1681.12453.

PMID:
26173818
18.

Novel integrase-defective lentiviral episomal vectors for gene transfer.

Vargas J Jr, Gusella GL, Najfeld V, Klotman ME, Cara A.

Hum Gene Ther. 2004 Apr;15(4):361-72.

PMID:
15053861
19.

Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.

Greenberg KP, Geller SF, Schaffer DV, Flannery JG.

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1844-52.

20.

Transgene expression in various organs post BM-HSC transplantation.

Wang N, Rajasekaran N, Hou T, Mellins ED.

Stem Cell Res. 2014 Jan;12(1):209-21. doi: 10.1016/j.scr.2013.10.010. Epub 2013 Nov 2.

Supplemental Content

Support Center